November 10, 2017Open Access

Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The Steering Committee recommends use of the defined clinically meaningful outcomes beyond HbA1c in the research, development, and evaluation of type 1 diabetes therapies.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Agiostratidou et al. (Fri,) studied this question.

synapsesocial.com/papers/69d7ec3f11d83f35e5ae33ec https://doi.org/https://doi.org/10.2337/dc17-1624

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar

Ver artículo completo